Monaco Asset Management SAM

Position in MRVI — Maravai Lifesciences Holdings, Inc.

CIK 1803593 Monaco, O9

Position in MRVI

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$9,681,486

-$1,564,131 QoQ

Shares Held

3,421,020

-1.1% QoQ

Ownership

1.32%

of shares outstanding

% of Portfolio

3.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Monaco Asset Management SAM holds $38,256,689 across 13 Biotechnology names. MRVI ranks #1 (25.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRVI	Maravai Lifesciences Holdings, Inc. This page	3,421,020	$9,681,486
2	RCKT	Rocket Pharmaceuticals, Inc.	2,058,303	$7,368,724
3	NVAX	Novavax Inc	697,600	$5,678,464
4	NKTX	Nkarta, Inc.	2,521,932	$5,321,276
5	PLRX	Pliant Therapeutics, Inc.	1,938,747	$2,442,821
6	BMRN	Biomarin Pharmaceutical Inc	30,000	$1,694,700
7	VNDA	Vanda Pharmaceuticals Inc.	241,286	$1,667,286
8	FATE	Fate Therapeutics Inc	810,000	$972,000

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,681,486	3,421,020	-1.1%	Shares	Sole	2026-05-11
2025-12-31	$11,245,617	3,460,190	-5.4%	Shares	Sole	2026-02-10
2025-09-30	$10,493,687	3,656,337	+315.0%	Shares	Sole	2025-11-10
2025-06-30	$2,123,125	880,965	+5.4%	Shares	Sole	2025-08-07
2025-03-31	$1,847,261	835,865	+186.9%	Shares	Sole	2025-05-08
2024-12-31	$1,587,933	291,364	+288.5%	Shares	Sole	2025-02-10
2024-09-30	$623,250	75,000	-62.5%	Shares	Sole	2024-11-07
2024-06-30	$1,432,000	200,000	+26.5%	Shares	Sole	2024-08-07
2024-03-31	$1,371,169	158,151	-49.2%	Shares	Sole	2024-05-09
2023-12-31	$2,038,425	311,210	—	Shares	Sole	2024-02-07
No filing history on record for this holder in this stock.